Chronic Disease Management with USA’s Biofourmis

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how Biofourmis is changing this.

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Chronic diseases, which include conditions like heart disease, stroke, diabetes and cancer, are so common in the U.S. that they drive a significant portion of the nation's healthcare costs. 

To treat such an extensive problem Biofourmis was founded by Kuldeep Singh Rajput and co-founded by Mark Niu and Maulik Majumda. They believe in providing personalized, predictive care for better outcomes. For this, they use advanced technology to improve the delivery of healthcare outside the hospital. The Boston-based company develops software to “augment” patient care and optimizes the delivery of virtual health. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers.

The venture has 2 subsets - Biofourmis Therapeutics and Biofourmis Health. For the former, pharmaceutical companies prescribe Biofourmis’ digital therapeutics for better managing chronic conditions. It follows ‘beyond the pill’ model. The latter is an AI-based remote monitoring system that helps clinicians remotely monitor patients and thereby improve patient outcomes. It follows ‘home hospital’ model. Biofourmis 

BiovitalsHF, a platform designed for heart failure medication monitoring received an FDA breakthrough device designation last year. BiovitalsHF is supposed to streamline the titration process once patients leave hospitals by collecting and analyzing data from a wearable device.

They have raised a total of $143.6 million in funding over 8 rounds. The venture has been invested by SG Innovate, MassMutual, Openspace Ventures, SpesNet, Sequoia, SoftBank and EDBI. In addition, Biofourmis will use the funding for developing, validating and commercializing several released and unreleased digital therapeutics solutions across cardiology, respiratory, oncology and pain, with a focus on the United States and key Asian markets, including the Asia Pacific, China and Japan.

Their health partners are NOVARTIS, Mayo Clinic, AstraZeneca, SingHealth, Mundipharma and more. Their 2 acquisitions are wearable biosensor leader Biovotion and Takeda Pharmaceuticals oncology-focused digital therapeutics company Gaido Health. Since COVID remote monitoring and digital therapeutics has gained momentum. Will ventures like Biofourmis make this more the forefront of medicine in the future too?

Tags : #Biofourmis #KuldeepSinghRajput #MarkNiu #MaulikMajumda #BiofourmisTherapeutics #BiofourmisHealth #chronicdisease #remotepatientmonitoring #USA-startup #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024
Chamraj Tea Estate Launches New Nilgiri Tea Blends: ‘Master Blend,’ ‘Master Blend Ginger Tea,’ and ‘Master Blend Lemon Tea’July 16, 2024
How a Fiber-Rich Diet and Gut Parasites Can Improve Your HealthJuly 16, 2024
LinkedIn: A Double-Edged Sword for Professional GrowthJuly 16, 2024
Food Safety and Drug Administration (FDA), Uttarakhand, National Association of Street Vendors of India (NASVI) and Nestlé India expand Project ‘Serve Safe Food’ in Uttarakhand July 16, 2024
IIT Kharagpur and University of Leeds Sign MoU for Joint Supervision of PhD ProgramsJuly 16, 2024
Puja Curtains go up with KHUTI PUJA at Hazra Park DurgotsabJuly 16, 2024
Algorand and SEWA Join Forces to Launch Digital Health Passport Initiative for Women's EmpowermentJuly 15, 2024
The Debate Over Menstrual Leave: Balancing Needs and Workplace EqualityJuly 15, 2024